Cargando…
Genetic heterogeneity and evolutionary history of high-grade ovarian carcinoma and matched distant metastases
BACKGROUND: High-grade serous ovarian carcinoma (HGSOC) is the most frequent type of ovarian carcinoma, associated with poor clinical outcome and metastatic disease. Although metastatic processes are becoming more understandable, the genomic landscape and metastatic progression in HGSOC has not been...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156387/ https://www.ncbi.nlm.nih.gov/pubmed/32099096 http://dx.doi.org/10.1038/s41416-020-0763-4 |
_version_ | 1783522195164626944 |
---|---|
author | Masoodi, Tariq Siraj, Sarah Siraj, Abdul K. Azam, Saud Qadri, Zeeshan Parvathareddy, Sandeep K. Tulbah, Asma Al-Dayel, Fouad AlHusaini, Hamed AlOmar, Osama Al-Badawi, Ismail A. Alkuraya, Fowzan S. Al-Kuraya, Khawla S. |
author_facet | Masoodi, Tariq Siraj, Sarah Siraj, Abdul K. Azam, Saud Qadri, Zeeshan Parvathareddy, Sandeep K. Tulbah, Asma Al-Dayel, Fouad AlHusaini, Hamed AlOmar, Osama Al-Badawi, Ismail A. Alkuraya, Fowzan S. Al-Kuraya, Khawla S. |
author_sort | Masoodi, Tariq |
collection | PubMed |
description | BACKGROUND: High-grade serous ovarian carcinoma (HGSOC) is the most frequent type of ovarian carcinoma, associated with poor clinical outcome and metastatic disease. Although metastatic processes are becoming more understandable, the genomic landscape and metastatic progression in HGSOC has not been elucidated. METHODS: Multi-region whole-exome sequencing was performed on HGSOC primary tumours and their metastases (n = 33 tumour regions) from six patients. The resulting somatic variants were analysed to delineate tumour evolution and metastatic dissemination, and to compare the repertoire of events between primary HGSOC and metastasis. RESULTS: All cases presented branching evolution patterns in primary HGSOC, with three cases further showing parallel evolution in which different mutations on separate branches of a phylogenetic tree converge on the same gene. Furthermore, linear metastatic progression was observed in 67% of cases with late dissemination, in which the metastatic tumour mostly acquires the same mutational process active in primary tumour, and parallel metastatic progression, with early dissemination in the remaining 33.3% of cases. Metastatic-specific SNVs were further confirmed as late dissemination events. We also found the involvement of metastatic-specific driver events in the Wnt/β-catenin pathway, and identified potential clinically actionable events in individual patients of the metastatic HGSOC cohort. CONCLUSIONS: This study provides deeper insights into clonal evolution and mutational processes that can pave the way to new therapeutic targets. |
format | Online Article Text |
id | pubmed-7156387 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-71563872020-04-23 Genetic heterogeneity and evolutionary history of high-grade ovarian carcinoma and matched distant metastases Masoodi, Tariq Siraj, Sarah Siraj, Abdul K. Azam, Saud Qadri, Zeeshan Parvathareddy, Sandeep K. Tulbah, Asma Al-Dayel, Fouad AlHusaini, Hamed AlOmar, Osama Al-Badawi, Ismail A. Alkuraya, Fowzan S. Al-Kuraya, Khawla S. Br J Cancer Article BACKGROUND: High-grade serous ovarian carcinoma (HGSOC) is the most frequent type of ovarian carcinoma, associated with poor clinical outcome and metastatic disease. Although metastatic processes are becoming more understandable, the genomic landscape and metastatic progression in HGSOC has not been elucidated. METHODS: Multi-region whole-exome sequencing was performed on HGSOC primary tumours and their metastases (n = 33 tumour regions) from six patients. The resulting somatic variants were analysed to delineate tumour evolution and metastatic dissemination, and to compare the repertoire of events between primary HGSOC and metastasis. RESULTS: All cases presented branching evolution patterns in primary HGSOC, with three cases further showing parallel evolution in which different mutations on separate branches of a phylogenetic tree converge on the same gene. Furthermore, linear metastatic progression was observed in 67% of cases with late dissemination, in which the metastatic tumour mostly acquires the same mutational process active in primary tumour, and parallel metastatic progression, with early dissemination in the remaining 33.3% of cases. Metastatic-specific SNVs were further confirmed as late dissemination events. We also found the involvement of metastatic-specific driver events in the Wnt/β-catenin pathway, and identified potential clinically actionable events in individual patients of the metastatic HGSOC cohort. CONCLUSIONS: This study provides deeper insights into clonal evolution and mutational processes that can pave the way to new therapeutic targets. Nature Publishing Group UK 2020-02-26 2020-04-14 /pmc/articles/PMC7156387/ /pubmed/32099096 http://dx.doi.org/10.1038/s41416-020-0763-4 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Masoodi, Tariq Siraj, Sarah Siraj, Abdul K. Azam, Saud Qadri, Zeeshan Parvathareddy, Sandeep K. Tulbah, Asma Al-Dayel, Fouad AlHusaini, Hamed AlOmar, Osama Al-Badawi, Ismail A. Alkuraya, Fowzan S. Al-Kuraya, Khawla S. Genetic heterogeneity and evolutionary history of high-grade ovarian carcinoma and matched distant metastases |
title | Genetic heterogeneity and evolutionary history of high-grade ovarian carcinoma and matched distant metastases |
title_full | Genetic heterogeneity and evolutionary history of high-grade ovarian carcinoma and matched distant metastases |
title_fullStr | Genetic heterogeneity and evolutionary history of high-grade ovarian carcinoma and matched distant metastases |
title_full_unstemmed | Genetic heterogeneity and evolutionary history of high-grade ovarian carcinoma and matched distant metastases |
title_short | Genetic heterogeneity and evolutionary history of high-grade ovarian carcinoma and matched distant metastases |
title_sort | genetic heterogeneity and evolutionary history of high-grade ovarian carcinoma and matched distant metastases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156387/ https://www.ncbi.nlm.nih.gov/pubmed/32099096 http://dx.doi.org/10.1038/s41416-020-0763-4 |
work_keys_str_mv | AT masooditariq geneticheterogeneityandevolutionaryhistoryofhighgradeovariancarcinomaandmatcheddistantmetastases AT sirajsarah geneticheterogeneityandevolutionaryhistoryofhighgradeovariancarcinomaandmatcheddistantmetastases AT sirajabdulk geneticheterogeneityandevolutionaryhistoryofhighgradeovariancarcinomaandmatcheddistantmetastases AT azamsaud geneticheterogeneityandevolutionaryhistoryofhighgradeovariancarcinomaandmatcheddistantmetastases AT qadrizeeshan geneticheterogeneityandevolutionaryhistoryofhighgradeovariancarcinomaandmatcheddistantmetastases AT parvathareddysandeepk geneticheterogeneityandevolutionaryhistoryofhighgradeovariancarcinomaandmatcheddistantmetastases AT tulbahasma geneticheterogeneityandevolutionaryhistoryofhighgradeovariancarcinomaandmatcheddistantmetastases AT aldayelfouad geneticheterogeneityandevolutionaryhistoryofhighgradeovariancarcinomaandmatcheddistantmetastases AT alhusainihamed geneticheterogeneityandevolutionaryhistoryofhighgradeovariancarcinomaandmatcheddistantmetastases AT alomarosama geneticheterogeneityandevolutionaryhistoryofhighgradeovariancarcinomaandmatcheddistantmetastases AT albadawiismaila geneticheterogeneityandevolutionaryhistoryofhighgradeovariancarcinomaandmatcheddistantmetastases AT alkurayafowzans geneticheterogeneityandevolutionaryhistoryofhighgradeovariancarcinomaandmatcheddistantmetastases AT alkurayakhawlas geneticheterogeneityandevolutionaryhistoryofhighgradeovariancarcinomaandmatcheddistantmetastases |